Company intelligence / Profile preview

Costa Brava Partnership

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Costa Brava Partnership is an activist investment firm and hedge fund based in Boston, Massachusetts, led by Seth Hamot. The firm specializes in identifying undervalued publicly traded companies and engaging in shareholder activism to unlock value through strategic alternatives, management changes, or corporate restructuring. While not a direct developer of therapeutics, Costa Brava Partnership has maintained a significant focus on the healthcare and life sciences sectors, notably influencing the strategic direction of companies like Bradley Pharmaceuticals and Nabi Biopharmaceuticals. The firm is recognized for its aggressive approach to corporate governance and its role in facilitating mergers and acquisitions within the pharmaceutical industry.

Industry: Investors

Beyond the preview

Go deeper on Costa Brava Partnership.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Costa Brava Partnership.

Explore the full profile